what glp-1 is approved for sleep apnea Tirzepatide medication known to improve apnea, but not all patients benefit equally. In a new study, presented at #ATS2026, Scott Sands, PhD, associate professor of medicine at Brigham and Indications for GLP-1/GIP RA Summary

The study also showed several cardiometabolic benefits of semaglutide with significant improvement in hemoglobin A1C, body weight, and cholesterol reduction compared to placebo

Treatment typically lasts 45-60 minutes

Research indicates retatrutide may help reduce liver fat and improve lipid profiles, preventing complications such as fatty liver disease

The glucagon component uniquely increases energy expenditure and fat oxidation, theoretically preventing the metabolic adaptation that typically limits weight loss with appetite suppression alone

Retatrutide at 12 mg weekly currently produces the largest weight loss of any published Phase 3 GLP-1-class compound, exceeding tirzepatide (22.5% in SURMOUNT-1) and semaglutide (14.9% in STEP-1) at comparable timepoints

GLP-1 drugs